Author name: Swaraj Paul Barooah

.

Guest Post: International Patent Filing Strategy Survey for Patent Attorneys in the Biotechnology and Pharmaceutical industries

/ By / Patent

One of our regular readers, a patent agent and law student from US has sent in a request for our patent attorney readers. Please see as below: Dear SpicyIP readers: A team of law students, who are members of the Intellectual Property law Fellowship at the Thomas Jefferson School of Law in San Diego, California, are working on a Research Project directed toward aiding patent attorneys in developing international patent filing strategies for biotechnology and pharmaceutical companies. With the help […]

Guest Post: International Patent Filing Strategy Survey for Patent Attorneys in the Biotechnology and Pharmaceutical industries Read More »

Update: Nexavar only for western patients

/ By / Patent

On January 21st, 2014 reporter Ketaki Gokhale of Bloomberg BusinessWeek published a shocking statement by Bayer Chief Executive Officer Marijn Dekkers as part of their story on drug patents and prices. With respect to the Nexavar drug which we’ve covered extensively on this blog, he was quoted as saying: “We did not develop this medicine for Indians,” “We developed it for western patients who can afford it.” Nexavar of course was the kidney cancer drug for which the IPAB upheld India’s

Update: Nexavar only for western patients Read More »

Patent analytics apps and an infographic of the Indian Patent System

/ By / Patent

Rubal Walia from Relecura sends us the infographic pictured below, on the state of Indian Patents by looking over data (sources mentioned in the note at the bottom) from the last few years. Their numbers indicate that while the number of patent applications has slowly been rising, the number of patents granted annually has decreased substantially. Those interested in patent analytics may also want to check out Bangalore/SF based Relecura’s mobile app which, to my knowledge, is one of only

Patent analytics apps and an infographic of the Indian Patent System Read More »

INTA’s 136th Annual Meeting

/ By / Event, Sponsored

The International Trademark Association’s (INTA) 136th Annual Meeting will be held in Asia for the first time – in Hong Kong SAR, China on May 10-14, 2014. The Annual Meeting has made its mark as the largest and most dynamic IP and trademark event in the world. More than 8,500 professionals from over 140 countries are expected to attend. Five days of international trademark and intellectual property education sessions led by the most acclaimed IP professional in the world will

INTA’s 136th Annual Meeting Read More »

Guest Post: Delhi HC simplifies a complex Asana

/ By / Copyright, Trademark

Sadhvi Sood brings us her third post in our 2nd Annual SpicyIP Fellowship applicant series. This post examines a recent Delhi High Court case wherein ‘pranic healing’, the phrase as well as techniques were claimed to be protected by trademark and copyright law respectively. You can view Sadhvi’s previous posts here. As a note for our readers, our application window for our Fellowship has now closed. We should hopefully be able to go through all the submitted applications and announce

Guest Post: Delhi HC simplifies a complex Asana Read More »

Guest Post: Is Nestlé Seeking a Patent over an Indian Home Remedy?

/ By / Traditional Knowledge

In this guest post, Sadhvi Sood discusses reports of Nestle’s patent application for Fennel Flower (Kala Jeera) vis-a-vis the concept of traditional knowledge. This is Sadhvi’s second submission to our SpicyIP Fellowship series. You can view her first submission here. Is Nestlé Seeking a Patent over an Indian Home Remedy? Since time immemorial, home remedies have been used in India to effectively treat both quotidian health problems like the common flu and chronic diseases like sinusitis etc. When it was reported

Guest Post: Is Nestlé Seeking a Patent over an Indian Home Remedy? Read More »

Guest Post: “Adaptation” of movies

/ By / Copyright, Trademark

Shashank Singh brings us his second submission for our Fellowship series. In this guest post, he looks at a topic we’ve often discussed on this blog in the past – The Hollywood to Bollywood script ‘diffusion’. You can view Shashank’s first submission here. Trend and Standard for judging infringement in ‘adaptation’ of movies Off late, Bollywood has been drawn towards remaking movies or re-releasing them with slight manipulation. They have also been accused of “heavily borrowing” scripts from Hollywood movies.

Guest Post: “Adaptation” of movies Read More »

Guest Post: When Man becomes a Brand

/ By / Copyright, Trademark

In this guest post, Deepshikha Malhotra, a 2nd year student from Faculty of Law, University of Delhi, raises some questions of what happens when a person becomes a ‘brand name’. This is Deepshikha’s first entry to our 2nd Annual SpicyIP Fellowship. [Note: We will be accepting submissions till 15th January] When Man becomes a Brand In our age of media and advertising, celebrities are paid crores just to endorse products. Their name or image is associated with the product and in

Guest Post: When Man becomes a Brand Read More »

A Look Back, As We Step Into 2014

/ By / Others

As we wish our readers a warm and fulfilling year ahead, we’d like to take this opportunity to glance back at the year that was. From the Novartis decision to the Marrakesh Treaty, from our new website to Aparajita’s legal notice – 2013 was certainly an eventful year for both the IP landscape as well as for our blog! SpicyIP Highlights: The year started off with some great news for the blog with Barry Sookman ranking SpicyIP as the 8th most

A Look Back, As We Step Into 2014 Read More »

Event: CPhl’s Pharma IPR, 2014

/ By / Event, Patent, Sponsored

CPhI’s 3rd Annual Pharma IPR 2014, is a very targeted conference focusing on patent related matters for Pharma and Biopharma Industry across the globe. It is an ideal learning and networking platform where techno-legal experts from patent law firms across the globe share an update on patent regimes, changes in patent laws, and enforceability of patent laws in different regions with the Pharma and Biopharma companies. The exclusive interactive format of the programme facilitates addressing of recent case laws, intense

Event: CPhl’s Pharma IPR, 2014 Read More »

Scroll to Top